Tafluprost / Timolol (Addendum to Commission A14-49) [Internet].

On 26 May 2015, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to conduct a supplementary assessment for Commission A14-49 (Tafluprost / timolol – Benefit assessment according to §35a SGB V).

http://ift.tt/2seExXK